Skip to main content
Equibles
ADCT $1.38 +8.27%
ADCT logo
ADCT · ADC Therapeutics SA
Track ADCT — free

Use ADCT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ADCT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.38 +0.11 (+8.27%)
Russell 2000 member Rebalance outlook locked
Market Cap
$160.22M
Shares
127.67M
Volume · Oct 7 735.28K Avg daily vol (3M) 1.39M
All webcasts

Earnings call · FY2026 Q2

ADC Therapeutics SA (ADCT) Q2 2026 Earnings Call

Concluded Aug 13, 2026
Aug 13, 2026 0 turns
Period
FY2026 Q2
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $19.25M +2.2% YoY
Diluted EPS -$0.11
Net income -$16.57M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Aug 13, 2026 10-Q report Filed Aug 13, 2026

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Product$18.63M +3% YoY
Royalty Revenue$614,000 -18.6% YoY
License Revenues$0
Full-screen source Call document

ADCT transcript alerts

ADC Therapeutics SA

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →